Early detection crucial in breast cancer treatment, emphasizes expert
October 24 2018 03:23 PM
National Center for Cancer Care and Research
The National Center for Cancer Care and Research's High-Risk Breast Screening and Genetics Program assessed over 800 patients last year

QNA/Doha

The National Center for Cancer Care and Research (NCCCR) has affirmed the importance of early detection of breast cancer at the age of 45 regularly, as breast cancer is by far the most common cancer in Qatar. 

With one in eight women diagnosed with breast cancer in their lifetime, it is the most common cancer affecting women worldwide. Senior Consultant at the National Center for Cancer Care and Research (NCCCR), Dr Salha Bujassoum, said Breast Cancer Awareness Month provides an opportune time to remind women about the importance of beginning regular breast cancer screening from the age of 45. 

Dr Bujassoum, who is also Director of the Hereditary Cancer and High-Risk Screening Program, said there are a number of genetic, environmental or lifestyle factors that can increase a womans risk of developing breast cancer. 

She said the team at NCCCRs High-Risk Breast Screening and Genetics Program assessed over 800 patients last year, noting that the service helps women understand their cancer risk based on a number of factors, including age, personal health history, and genetic or family history. 

The High-Risk Breast Screening and Genetics Program provides genetic counseling and testing services to patients who are concerned about their hereditary cancer risk because of a personal and/or family history, Dr Bujassoum added. 

"Genetic counseling can be very helpful for those who have a strong family history of breast cancer. Evaluations are carried out by a specialist board-certified genetic counselor and this specialist can help assess an individual’s lifetime risk of developing cancer," said Dr Bujassoum. 

Dr Bujassoum noted that the Hereditary Cancer and High-Risk Screening Program is the first of its kind in the region. Genetic testing is performed through the Molecular Diagnostic Laboratory, with some tests being sent abroad for analysis. Based on the patients individual risk assessment, appropriate counseling, testing and prevention measures are offered to reduce the likelihood and incidence of breast and other types of cancer. 

"Our multidisciplinary and collaborative approach sees a team of specialists, which includes genetic counselors, psychologists, surgeons, and medical oncologists, working together to develop the best plan of care for each and every patient. After their assessment, our team discusses risk-reducing strategies with the patient," Dr Bujassoum added.

The Hereditary Cancer and High-Risk Screening Program is an example of a multidisciplinary service that aims to achieve excellence in cancer care through offering prevention and personalized medicine and supports the National Cancer Framework 2017-2022 Achieving Excellence in Cancer Care: A Vision for 2022. This program is the first of its kind in the Middle East and has positioned Hamad Medical Corporation (HMC) as a leader and innovator in patient-and family-centered care. 

"In addition to our role as cancer and genetic experts, we raise awareness about the familial and hereditary risk of breast and other types of cancers. Our ultimate goal is to provide an expert evaluation for the management of high-risk patients," said Dr Bujassoum.



There are no comments.

LEAVE A COMMENT Your email address will not be published. Required fields are marked*
MORE NEWS